Importantly, high levels of both Sp4 and ANGPTL4 significantly correlated with poor prognosis (lower panel, Figure 5E–F), suggesting a positive correlation of Sp4 with ANGPTL4 in GBM patients. Here, ANGPTL4 is linked to glioblastoma.